Navigation Links
SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride
Date:7/24/2008

continue living an active lifestyle."

Additional information on the "Mark's Breathe Easy Tour" and Mark's journey is available at http://www.sequal.com/corp_event.php.

ABOUT THE AMERICAN LUNG ASSOCIATION

Beginning their second century, the American Lung Association is the leading organization working to prevent lung disease and promote lung health. Lung disease death rates continue to increase while other leading causes of death have declined. The American Lung Association funds vital research on the causes of and treatments for lung disease. With the generous support of the public, the American Lung Association is "Improving life, one breath at a time," through events like Healthy Air Walks, http://www.healthyairwalk.org and Breathe Easy Rides, http://www.breatheasyride.org. For more information about the American Lung Association or to support the work it does, call 1-800-LUNG-USA (1-800-586-4872) to reach your nearest American Lung Association office and/or to speak with a registered nurse or respiratory therapist about any lung health questions or visit http://www.californialung.org or http://www.lungusa.org.

ABOUT SETON MEDICAL CENTER

Seton Medical Center is a member of the Daughters of Charity Health System. The Mission of the Daughters of Charity of St. Vincent de Paul is to provide compassionate, spiritually focused care to the sick, poor and underserved. Seton, with more than 600 physicians, offers the most advanced surgical procedures, treatment options, and comprehensive health care services available. Seton Medical Center's Centers of Excellence, each with nationally acclaimed clinical outcomes, include The San Francisco Heart & Vascul
'/>"/>

SOURCE SeQual Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. San Diegos SeQual Technologies Loans 35 Portable Oxygen Units to Evacuees at Qualcomm Stadium
2. US Army Purchases SeQuals Cutting-Edge Oxygen Generation Technology for MRAP Deployment
3. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
4. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
5. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
6. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
7. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
8. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
9. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
10. ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
11. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ders to be held on January 8, 2009 , , TORO...ternational Inc. ("MedEmerg") (OTCBB: MDER), one o...nnounced today that it has obtained an interim ord...erning its previously announced plan of arrangemen... Group Inc. ("AIM") will acquire all of MedEmerg,s...
(Date:11/21/2008)...University of Texas Health Science Center at Houst...in Aging Studies (TEXAS), to promote geriatrics tr...lion award from the Donald W. Reynolds Foundation ...allow us to teach geriatric medicine principles to...practicing physicians. With the reach of Lyndon B....
(Date:11/21/2008)...RNewswire-FirstCall/ -- Heska Corporation,(Nasdaq...New York Society of,Security Analysts, 12th Annua...mber 2, 2008 at 1177 Avenue of the Americas, 2nd F...ed to begin at 9:35 a.m. Eastern Time (7:35 a.m.,...ast and for two weeks,following the presentation ...
(Date:11/21/2008)...Newswire-USNewswire/ -- The Generic,Pharmaceutica...ent today from,GPhA President and CEO Kathleen Ja... roundtable on "Emerging Health Care Competition a...the FTC is conducting this roundtable demonstrates...ers have access to safe and,affordable biogeneric...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...n celebration of National Sleep Awareness Week, Ma...er for Sleep Disorders is encouraging people who s...hey) gasp for air at night or wake up groggy to be...ially deadly, but easily treatable, sleep disorder...
...or the first time, experimental results indicate t... harmful prion proteins from the blood of an infec...s for the removal of infectious prion proteins – t...ob disease, mad cow disease, scrapie and other pri...
...engue fever is likely to resurface in Vietnam in A...curbed, the Ministry of Health has warned.// In ...he ministry warned that Vietnam’s mosquito populat...ue fever – has increased dramatically recently. Th...
...ne in 18 men and women will be diagnosed with colo...lates into more than 150,000 people diagnosed // a...year, securing the disease as the second leading c...tes. Fortunately, mortality rates for this disea...
Other Medicine News:Health News:Sleep Apnea: Take It to Heart, Loyola Advises 2Health News:Researchers Develop Resin Beads That Capture Mad Cow Disease Agent From Blood 2
(Date:11/20/2008)... PRELIMINARY TOP LINE RESULTS OF FIRST PHASE ... AND FATIGUE, AND IMPROVEMENT IN DAILY FUNCTION, I...TS, , PALO ALTO, Calif., and BRUSSELS, Belgium...uticals, Inc. (Nasdaq: JAZZ ) and UCB (Euronext ...ry top-line results from the first of two,Phase I...
(Date:11/20/2008)... LA JOLLA, Calif., Nov. 20 /PRNewswire-FirstCall/...: DSKA), announced today that it has submitted its...or review under a Special,Protocol Assessment (SP...ation,(FDA). , Subject to securing an agre...ingle, prospective, double-blind, placebo-controll...
(Date:11/20/2008)... TROMSO, Norway, November 20 ...ytix Biopharma has announced results of studies on...ted at ICAAC in Washington, DC,the studies showe...-rapid,bacteriocidal effect, significantly better...ococcus pyogenes than marketed gold standard drugs...
(Date:11/19/2008)... St. Jude scientists report basic findings on cri...nding how to better treat an array of disorders ,...swire/ -- Scientists at St. Jude Children,s Resea...ion of one of the body,s enzyme workhorses called ...achievers, calpains function in many cellular proc...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Researchers find new taste in fruit flies 3A carbonated water 182 1Researchers find new taste in fruit flies 3A carbonated water 182 2Researchers find new taste in fruit flies 3A carbonated water 182 3Influence of sex and handedness on brain is similar in capuchin monkeys and humans 179 1Influence of sex and handedness on brain is similar in capuchin monkeys and humans 179 2Scientist evangelical Alaska expedition 176 1Scientist evangelical Alaska expedition 176 2Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology 247 1Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology 247 2
...ime to pain progression is 66.1 weeks for the,satr...bo arm --,Hazard ratio of 0.64 (95% CI: 0.51-0.79,...ative risk of pain progression, MARTINSRIED/MUNICH...PRINCETON, N.J., and BOULDER, Colo. -- GPC Biotech...resentation of additional,data from the double-bli...
...ented at 2007 APA Meeting -, COLLEGEVILLE, Pa., Ma...r new studies examining safety and efficacy of,des...reuptake,inhibitor (SNRI) being studied as a poten...sorder (MDD), were presented today at the,2007 Ame...n Diego,Calif., by Wyeth Pharmaceuticals, a divis...
Other Medicine Technology:Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 2Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 3Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 4Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 5Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: